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Wednesday, February 11, 2015 581awas subjected to in vitro cRNA synthesis. The resulting cRNA was subse-
quently injected into Xenopus oocytes, and channel currents were examined us-
ing Two-Electrode Voltage Clamp four days later. We thus compared the
biophysical properties of WT and mutant channels. We found that the
R477H mutation shifts the voltage dependence of inactivation to more depolar-
ized voltages, rendering the mutant channels more difficult to inactivate
compared to the WT channel. In addition, the time constant of inactivation
was slower for the mutant. At the same time, the voltage dependence of activa-
tion was unchanged. These results suggest a potential mechanism for epilepto-
genesis: reduced channel inactivation would contribute to increased cellular
excitability and excitotoxicity - two hallmarks of epilepsy. The results also
highlight the role of the I-II loop of VGCC in channel inactivation. As for
the Q1957X mutation, our current hypothesis is that this mutant generates no
currents. In addition, we hypothesize that the Q1957X mutant will act as a
dominant negative regulator of coexpressed WT channels via the unfolded pro-
tein response.
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The human L-type calcium channel (CaV1.2) is a multi-protein complex
consisting of the pore-forming a1c subunit and at least two auxiliary subunits,
b and a2d, which assemble in a 1:1:1 stoichiometry. b subunits regulate mul-
tiple aspects of CaV1.2 channel physiology, including surface expression,
degradation and gating. Investigating the effect of b2a and b3 subunits on
human CaV1.2 channels (a1cþa2d) expressed in Xenopus oocytes, we found
that the voltage dependences of total charge displacement (QV) and conduc-
tance (GV) were ~10mV more negative in the presence of b2a. We tested
the hypothesis that b2a and b3 subunits differently modulate the activation
of the four voltage-sensor domains (VSDs) in the a1c subunit. Using the
Voltage-Clamp Fluorometry technique, we fluorescently tracked the move-
ment of individual VSD in conducting human CaV1.2 channels. We found
that, in the presence of b2a, the voltage-dependent activation of VSDs II
and III was left-shifted as compared to b3-associated CaV1.2 (VSD II
with b2a: Vhalf¼ 31.151.0 mV, z¼ 4.550.8 e0; VSD II with b3: Vhalf¼
26.551.8 mV, z¼ 2.450.1 e0; VSD III with b2a: Vhalf¼ 36.653.9 mV,
z¼ 1.850.1 e0; VSD III with b3: Vhalf¼ 16.951.4 mV, z¼ 1.250.1 e0).
Moreover, activation and deactivation kinetics of VSD II in channels asso-
ciated with b2a were dramatically slower than in the presence of b3, while
voltage- and time-dependent properties of VSD IV remained the same in
the presence of either Cavb subunit. These results suggest that, in spite of
their highly-conserved sequence homology, different b subunit isoforms
distinctly modulate the biophysical properties of CaV1.2 voltage sensors to
mediate their effect on Ca conductance.2937-Pos Board B367
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The a2d-1 auxiliary subunit binds to the pore-forming a1c subunit of voltage-
gated L-type calcium channels (CaV1.2) and facilitates both membrane
trafficking and voltage-dependent activation. Using voltage-clamp fluorometry
to study human CaV1.2 channels expressed in Xenopus oocytes, we have
recently found that a2d-1 association, in the presence of b3 subunits, causes
voltage sensor domains (VSDs) I, II and III, but not IV, to activate at more hy-
perpolarized potentials (DVhalf¼ 39mV, 32mV, 18mV for VSDs I-III
respectively) and with steeper voltage-dependence (z fold increase with a2d-
1: 1.9, 2.2 and 1.6 for VSDs I-III respectively). Thus, the a2d-1-induced
facilitation of CaV1.2 voltage-dependent activation seems to be mediated
through the remodeling of three VSDs.
We analyzed our voltage-clamp fluorometry data with a 32-state allosteric
model for CaV1.2 activation, consisting of five gating particles (one pore,
four VSDs). By simultaneously fitting kinetic and steady-state data fromthe pore (ionic currents) and from the individual VSDs (fluorescence), we
estimated the energetic contribution of each VSD to pore opening in the
presence and in the absence of a2d-1. The model predicts that, in channels
not associated with a2d-1, all VSDs were poorly energetically-coupled to
pore opening. The association of a2d-1 with a1cþb3 specifically increased
the coupling energy of VSDs II and III to the pore. In agreement with the model
prediction, we found that without a2d-1 subunits the ionic current deactivation
is largely voltage-independent.
A low-resolution structure of CaV1.2 channel complexes shows that the a2d-1
subunit forms a cap that embraces ~3=4 of the extracellular surface of the a1c
subunit (Walsh et al., JBC 2009). Based on our results, we propose that the
exposed ¼ of the a1c subunit is VSD IV, which does not show evidence of
functional interaction with a2d-1 subunits.2938-Pos Board B368
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Pain signaling is initiated by the detection of noxious stimuli through
specialized primary nociceptors located in peripheral endings in dorsal
root ganglion (DRG) neurons. Low voltage activated CaV3.2 T-type calcium
channels play a major role in sensory perception in these neurons; silencing
their activity with antisense RNA or genetic ablation results in anti-
nociceptive, anti-hyperalgesic and anti-allodynic effects1-3. These channels
are regulated by a plethora of proteins, including KLHL1, a neuronal actin
binding protein that stabilizes channel activity by increasing its recycling
back to the plasma membrane via recycling endosome activity. We explored
the role of KLHL1 and its effects on CaV3.2 and mechanical peripheral pain
transmission using the KLHL1 KO mouse model. Total T-type calcium cur-
rent amplitude was smaller in KO DRG neurons (12 5 2.03 pA/pF, n¼18)
compared to controls (18 5 1.89 pA/pF, n¼13; p<0.05), without significant
changes in voltage dependence as expected in the absence of its modulator.
Western blot analysis confirmed CaV3.2 but not CaV3.1 or CaV3.3 protein
was significantly decreased. Interestingly, von Frey hair tests show paw
withdrawal threshold in KO mice was increased. Our data establishes
KLHL1 is a calcium channel regulator in DRG neurons, providing a novel
target to control peripheral pain sensation. Downregulation of CaV3.2 acti-
vity by as little as ~30% was sufficient to alter pain perception in the KO
model.2939-Pos Board B369
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Duchenne Muscular Dystrophy (DMD) is a fatal muscle wasting disorder. It is
commonly associated with cardiomyopathy that is characterised by disrupted
cytoskeletal architecture and mitochondrial dysfunction. Activation of the
L-type Ca2þ channel (LTCC) provides the Ca2þ influx required for contraction,
but also causes an increase in mitochondrial membrane potential (Jm) in a
calcium-independent manner. This involves the movement of cytoskeletal
proteins and regulation of mitochondrial VDAC. The increase in Jm (JC-1
fluorescence) after activation of LTCC is absent in cardiomyocytes isolated
from hearts of mdx mice, a murine model of DMD (1.551.0%, n¼4 vs.
12.151.4%, n¼10 in C57BL/10ScSnArc controls) but can be restored
using antisense morpholino oligomers to induce exon skipping of dystrophin
exon 23 (M23D). Here we investigate the effects of M23D peptides on
changes in Jm and mitochondrial oxygen consumption (flavoprotein auto-
fluorescence) induced by LTCC activation. Male (M) and female (F) neonatal
mdx mice were injected (i.p.) for 3 weeks and divided into two treatment
groups: (i) 120mg/kg once per week; (ii) 30mg/kg four times per week.
Activation of LTCC with the dihydropyridine agonist BayK(-) induced an
increase in Jm in cardiomyocytes from animals treated with a single weekly
dose (M: 1752%, n¼5; F: 1653%, n¼12) and with multiple weekly doses
582a Wednesday, February 11, 2015(M: 1652%, n¼6; F: 1352%, n¼15). BayK(-) increased flavoprotein
oxidation in mdx cardiomyocytes from animals treated with a single weekly
dose (M:1353%, n¼13; F: 1053%, n¼9) and with multiple doses per
week (M: 1752%, n¼16; F: 1452, n¼24). These data indicate that either
single or multiple i.p. injections per week of morpholino oligo peptides are
effective at restoring cardiac mitochondrial function in both male and female
mdx mice.
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Endolysosomal organelles play a key role in trafficking, breakdown and
receptor-mediated recycling of different macromolecules such as low-
density lipoprotein (LDL)-cholesterol, epithelial growth factor (EGF) or
transferrin. In the liver, receptor-mediated uptake of low-density lipoproteins
(LDLs) and subsequent intracellular transport is essential for hepatic choles-
terol homoeostasis and plasma lipoprotein metabolism. Dysfunction within
this pathway results in liver disease such as non-alcoholic fatty liver disease
(NAFLD), which is associated with increased cardiovascular and liver-
related mortality. It has been estimated that as many as 30% of adults
in these countries have NAFLD. This liver disease has thus emerged as a
substantial public health concern. Here, we examine the role of two-pore
channel (TPC) 2, an endolysosomal cation channel, in these processes.
Embryonic mouse fibroblasts were generated from wild type and TPC2 defi-
cient mice and characterized by single lysosome patch clamp employing
conventional patch clamp as well as planar patch clamp. In addition, traf-
ficking assays were performed. Embryonic mouse fibroblasts and hepato-
cytes lacking TPC2 display a profound impairment of LDL-cholesterol
and EGF/EGF-receptor trafficking. Mechanistically, both defects can be
attributed to a dysfunction of the endolysosomal degradation pathway
most likely on the level of late endosome to lysosome fusion. Importantly,
endolysosomal acidification or lysosomal enzyme function are normal in
TPC2-deficient cells. TPC2-deficient mice are highly susceptible to hepatic
cholesterol overload and liver damage consistent with non-alcoholic
fatty liver hepatitis. These findings indicate reduced metabolic reserve of
hepatic cholesterol handling. Our results suggest that TPC2 plays a crucial
role in trafficking in the endolysosomal degradation pathway and, thus, is
potentially involved in the homoeostatic control of many macromolecules
and cell metabolites.
Ion Channels, Pharmacology, and Disease
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Coronaviruses (CoV) are vertebrate pathogens that cause common colds, bron-
chiolitis and acute respiratory distress syndrome. In fact, their relevance
increased when the causative agent of the severe acute respiratory syndrome
(SARS) was identified as a CoV. CoV E protein is a small transmembrane pro-
tein of between 76-109 amino acids in length that modulates coronavirus
morphogenesis, tropism and virulence [1].
We sought to elucidate the role of E protein IC activity in virus pathogenesis
by combining our knowledge of residues essential for E protein ion conduc-
tivity with the manipulation of SARS-CoV genome. To test the contribution
of E protein IC activity in virus pathogenesis, two recombinant mouse-
adapted SARS CoVs, each containing one single amino acid mutation that
suppressed ion conductivity, were engineered. After serial infections, mutant
viruses, in general, incorporated compensatory mutations within E gene
that rendered active ion channels. Furthermore, IC activity conferred better
fitness in competition assays, suggesting that ion conductivity represents an
advantage for the virus. Interestingly, mice infected with viruses displaying
E protein IC activity, either with the wild-type E protein sequence or withthe revertants that restored ion transport, rapidly lost weight and died. In
contrast, mice infected with mutants lacking IC activity, which did not incor-
porate mutations within E gene during the experiment, recovered from disease
and most survived.
We have shown that SARS-CoV E protein IC activity is a virulence
determinant.
[1] DeDiego, M.L., et al 2008. Virology 376, 379-389.
[2] Verdia´-Ba´guena C., et al. 2012. Virology. 432: 485-494.
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Influenza A virus (IAV) exhibits a high mutation frequency. Mutations in the
proton channel M2 have created substantial IAV drug resistance to previously
effective drugs, such as amantadine (AMT), along with its analogs. The main
drug-resistant variation in the M2 proton channel, which has become ubiqui-
tous in humans, is the mutation S31N. Divalent copper has previously been
shown, using in vitro assays involving SSNMR and Xenopus oocytes, to bind
and block wild type M2 at the His37 selectivity filter. Here we report initial
tests of the hypothesis that, given the essential, conserved nature of the selec-
tivity filter, a complex consisting of copper bound to an amantadine derivative
might serve as a broad-spectrum anti-IAV drug. The EC50 of AMT, two AMT
analogs, CuCl22H2O, and four previously published Cu2þ complexes were
tested for antiviral activity against the California/07/2009 (H1N1) IAV strain
containing the S31N M2 proton channel in viral mini-plaque assays and for
M2(22-62, S31N)-mediated proton transport block in liposomes. A novel,
AMT-based divalent copper compound, NAG 107, emerged as a plausible
lead with an EC50 of 2.91 5 0.29 mM in the viral mini-plaque assay and
4.5 5 0.6 mM in the liposome assay, 21-fold and 11-fold better than amanta-
dine in these assays, respectively.
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Drug-induced block of ‘Human ether-a-go-go-related Gene’ (hERG) Kþ chan-
nels is the main reason of long QT syndrome, a disorder of cardiac repolariza-
tion which may lead to sudden death due to ventricular fibrillation. This side
effect has been the most frequent cause for drug withdrawal from the pharma-
ceutical market. For this reason, understanding the molecular determinants of
hERG channel inhibition is an interesting strategy to avoid the cardiotoxicity
of drugs.
Lubeluzole, a neuroprotective compound, has been associated with the
acquired long QT syndrome and ventricular arrhythmias; however its effects
on the hERG Kþ channel have not been described to date. Thus, the molecular
determinants for lubeluzole action on hERG channel were studied using the
patch clamp technique. We found that lubeluzole and its enantiomer are highly
potent inhibitors of hERG current with an IC50 value of around 10 nM
(no stereoselectivity observed). Moreover we observed that hERG inhibition
by lubeluzole is time- and voltage-dependent. In fact lubeluzole causes a nega-
tive shift in the voltage dependence of hERG current activation and accelerates
tail current deactivation, suggesting that it preferentially blocks the activated
state of the channel.
To go further in details, we synthesized a series of lubeluzole congeners
designed to explore the role of lipophilicity and electronic distribution.
Structural variations were designed on the basis of the indications gained by
quantum-mechanical calculations run at several DFT levels.
For each compound we determined the relative hERG affinity and the state-
dependent mechanism, to evaluate how specific modification of drug structure
affected hERG binding interaction. Main SAR results will be presented.
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Calcium-activated potassium channels, including the intermediate-conduc-
tance KCa3.1 channel and the related small-conductance KCa2 channels,
